MedTrace Logo

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin

NCT01763749 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2015-03-03

No results posted yet for this study

Summary

The Aim of this study is to prove non-inferiority of Closone to the Combination treatment of Plavix with Astrix.

Conditions

Interventions

DRUG

Closone

Closone 75mg/100mg, 4weeks, PO

DRUG

Plavix with Astrix

Plavix 75mg with Astrix 100mg, 4weeks, PO

Sponsors & Collaborators

  • Seoul St. Mary's Hospital

    lead OTHER

Principal Investigators

  • Ki-Bae Seung, MD, PhD · Cardiovascular center and Cardiology Division, Seoul St. Mary's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763749 on ClinicalTrials.gov